Tribehenin

Tribehenin is a lipid of Glycerolipids (GL) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Tribehenin

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tribehenin

MeSH term MeSH ID Detail
Edema D004487 152 associated lipids
Angina Pectoris D000787 27 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Total 3

NCBI Entrez Crosslinks

All references with Tribehenin

Download all related citations
Per page 10 20 50 100 | Total 169
Authors Title Published Journal PubMed Link
Zhang W et al. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology. 2013 Int J Pharm pmid:23876384
Gan L et al. Novel pH-sensitive lipid-polymer composite microspheres of 10-hydroxycamptothecin exhibiting colon-specific biodistribution and reduced systemic absorption. 2013 J Pharm Sci pmid:23605625
Patere SN et al. Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC study. 2013 Curr Drug Deliv pmid:23607649
Bose S et al. Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. 2013 Int J Pharm pmid:23262430
Wolska E and Sznitowska M Technology of stable, prolonged-release eye-drops containing Cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM). 2013 Int J Pharm pmid:23164704
Vaghasiya H et al. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. 2013 Eur J Pharm Sci pmid:23557842
Videira MA et al. Experimental design towards an optimal lipid nanosystem: a new opportunity for paclitaxel-based therapeutics. 2013 Eur J Pharm Sci pmid:23528739
Vithani K et al. Sustained release solid lipid matrices processed by hot-melt extrusion (HME). 2013 Colloids Surf B Biointerfaces pmid:23759381
Vora C et al. Risk based approach for design and optimization of stomach specific delivery of rifampicin. 2013 Int J Pharm pmid:23916823
Acevedo-Morantes CY et al. Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells. 2013 Drug Deliv pmid:24024505